Emery et al. (2015) depicted that TRPA1 exists in mouse intestinal endocrine cells and that its activation promotes GLP-1 in a calcium-dependent manner, which might be a target for the treatment of diabetes. This evidence concerns the gene TRPA1 and diabetes mellitus.